JP Morgan Chase’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-482,336
Closed -$60.1M 4489
2013
Q3
$60.1M Sell
482,336
-5,813,966
-92% -$736M 0.02% 710
2013
Q2
$547M Buy
+6,296,302
New +$580M 0.17% 130

JP Morgan Chase's ONXX Position: Q4 2013 in Review

JP Morgan Chase sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q4 2013, closing a stake of 482,336 shares — an estimated $60.1M sold.

JP Morgan Chase first reported a position in ONXX in Q2 2013 and held it in 2 quarters. The position peaked at $547M in Q2 2013. 0 funds tracked by Wall St. Rank hold ONXX as of Q4 2013.

  • JP Morgan Chase reported no remaining ONYX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • JP Morgan Chase sold 482,336 ONYX PHARMACEUTICALS INC shares in Q4 2013, an estimated $60.1M.
  • JP Morgan Chase first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • JP Morgan Chase's ONYX PHARMACEUTICALS INC position peaked at $547M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q4 2013.

Based on JP Morgan Chase's 13F filing for Q4 2013, filed 13 Feb 2014.